Skip to main content

Reporter May 10 2019

Nettles receives Nashville Cable’s Power of Inclusion Individual Award

May. 8, 2019—Vanderbilt's Arie Nettles, PhD, was named as the 2019 recipient of Nashville Cable’s Power of Inclusion Individual Award at a luncheon and ceremony held May 8.

Read more

Commencement 2019

May. 8, 2019—Vanderbilt University's 2019 Commencement ceremonies begin at 9 a.m. Friday, May 10.

Read more

Kidney transplant patient, brother share 40-year journey

May. 8, 2019—In 1979, Patsy Williams and her brother, Barry Ford, made a decision that has given her many more years of life. Ford gave Williams his kidney at Vanderbilt University Medical Center. They recently gathered for a luncheon to celebrate the 40th anniversary of Williams' transplant, along with dozens of their closest friends and family. She is thought to have lived longer with her transplant than anyone else who received one at Vanderbilt.

Read more

Adult Hospital CEO Edgeworth to depart VUMC

May. 7, 2019—Mitchell Edgeworth, MBA, Chief Executive Officer of Vanderbilt University Adult Hospital, has accepted a new position as Chief Administrative Officer — South with the TriStar Division of Hospital Corporation of America, and will be leaving Vanderbilt University Medical Center this month.

Read more

Bioimpedance spectroscopy better than tape measure for identifying lymphedema risk

May. 3, 2019—Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema.

Read more

VUMC, UCSF win KidneyX award for home dialysis design

May. 3, 2019—A roadmap to create an implantable dialysis system that would allow patients to treat kidney failure at home has won researchers from Vanderbilt University Medical Center (VUMC), UC San Francisco (UCSF), and Silicon Kidney one of 15 cash prizes in the inaugural KidneyX’s Redesign Dialysis Phase I competition.

Read more

Researchers putting the brakes on lethal childhood cancer

May. 3, 2019—Malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers. Although rare — about 20 to 25 new cases are diagnosed annually in the United States — there is no standard effective treatment for the disease, which is driven by loss of an anti-cancer protein called SNF5. The chances are very small that a child will survive a year after MRT diagnosis.

Read more

Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
VUMC Voice